A. G. Prentice - Concepedia

Author

A. G. Prentice

Also Known As

A G Prentice, A Prentice, A. G. PRENTICE, A. G. Prentice, A. Prentice, A.G. PRENTICE, A.G. Prentice, ARCHIBALD G. PRENTICE, Archibald G Prentice, Archibald G. Prentice

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Derriford Hospital University College London The Royal Free Hospital University of Birmingham University of Plymouth

About

A. G. Prentice is an author at Derriford Hospital specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	2.2K
2	Health Sciences	8	8	723
3	Public Health	4	4	266
4	Law	1	1	16
5	Biostatistics	1	1	236

A. G. Prentice

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J. McLaren, A. G. Prentice, D. Stephen Charnock‐Jones, Journal of Clinical Investigation EndometriosisImmunologyGynecologyPathologyMenstrual Cycle	1996	497
Randomised trial of intravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma Helen Chapel, M. Lee, R Hargreaves, The Lancet Hematological MalignancyLymphoid NeoplasiaIntravenous ImmunoglobulinImmunologyHematology	1994	258
Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials Keith Wheatley, Cassandra Brookes, Andrew Howman, British Journal of Haematology AgingElderly PatientsMrc Aml11Mixed-phenotype Acute LeukemiaPrognosis	2009	236
Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 Trial Alan K. Burnett, Robert K. Hills, Donald Milligan, Journal of Clinical Oncology	2009	226
A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies G.R. Morgenstern, A. G. Prentice, H. G. Prentice, British Journal of Haematology	1999	201
Fludarabine‐related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia Han Myint, J. A. Copplestone, Jennifer Orchard, British Journal of Haematology Hematological MalignancyImmunohematologyHaemolytic AnaemiaAutoimmune DiseaseChronic Lymphocytic Leukaemia	1995	186
ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL) Sarah J. Richardson, Christine Matthews, Mark Catherwood, Blood	2005	185
The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial Alan K. Burnett, Donald Milligan, Anthony P. Goldstone, British Journal of Haematology Mixed-phenotype Acute LeukemiaPharmacotherapyMyeloid NeoplasiaHematological MalignancyThrombosis	2009	140
The plasminogen activator system in women with polycystic ovary syndrome William Atiomo, Susie A Bates, John E. Condon, Fertility and Sterility InfertilityFemale InfertilityReproductive HealthGynecologyPathology	1998	128
The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA Alan K. Burnett, Robert K. Hills, Claire Green, Blood	2009	112

Page 1